Dalila C Pinto

Dalila C Pinto, PhD, is an Associate Professor at Icahn School of Medicine at Mount Sinai, with joint appointments in Psychiatry and Genetics and Genomic Sciences. She holds affiliations with the Seaver Autism Center, Mindich Child Health Institute, Friedman Brain Institute, Icahn Genomics Institute, and the PsychENCODE Consortium.

Her research integrates genomics, transcriptomics, and bioinformatics to study neuropsychiatric disorders. Key focus areas include:

• Genetic architecture of autism, epilepsy, and schizophrenia
• Brain-specific gene regulation and proteomics
• De novo mutations and rare variants in neurodevelopmental disorders
• Computational frameworks for multi-omics data analysis

Recent publication trends (2020-2024) highlight her work on brain proteomics in psychiatric disorders, epilepsy genetics, stem cell transcriptomics, and schizophrenia risk loci. Her team consistently contributes to large consortia like PsychENCODE and Epi25, emphasizing translational genomics.

Dr. Pinto leads the Pinto Lab, which develops innovative genomic approaches to map disease mechanisms. The lab is based in the Hess Center for Science & Medicine and collaborates internationally to advance neuropsychiatric research.